Skip to main content
Hedy Kindler, MD, Oncology, Chicago, IL

Hedy L Kindler MD

Oncology•Chicago, IL

Hematologic Oncology, Thoracic Cancer

Professor of Medicine and Associate Dean for Clinical Science Research, University of Chicago

Join to view full profile

  • 5841 S Maryland Ave, MC 2115Chicago, IL 60637

  • Phone+1 773-702-0360

  • Fax+1 773-702-3163

Dr. Kindler is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Kindler's full profileAlready have an account?

Summary

  • Dr. Hedy Kindler is an oncologist specializing in mesothelioma, based in Chicago, IL. She completed her medical education at the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo and underwent residency training at UCLA and Montefiore Medical Center, followed by a fellowship at Memorial Sloan Kettering Cancer Center. Dr. Kindler currently practices at the University of Chicago Pritzker School of Medicine where she is a Professor of Medicine and Associate Dean for Clinical Science Research. She is experienced in pleural, peritoneal, and tunica vaginalis mesothelioma. She has been recognized as a top doctor by various organizations and has published numerous articles on mesothelioma and cancer treatment. Her involvement in clinical trials includes studies on mesothelioma and evaluating novel therapies.

Clinical Expertise

  • Mesothelioma, Clinical research

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1992 - 1995
  • Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)
    Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 1991 - 1992
  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1989 - 1991
  • Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo
    Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 1989

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 1998 - 2029
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Chicago Magazine: Top Doctors Castle Connolly, 2008-2024
  • Wagner Medal International Mesothelioma Interest Group, 2023
  • Pioneer Award Mesothelioma Applied Research Foundation, 2022

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Dynamic Contrast-Enhanced CT for the Assessment of Tumour Response in Malignant Pleural Mesothelioma: A Pilot Study  
    Hedy L Kindler, Christopher M Straus, European Radiology

Other

Authored Content

  • Phase II Trial of Veliparib in Patients with Previously Treated BRCA-Mutated Pancreas Ductal Adenocarcinoma☆January 2018
  • Phase II Trial of Veliparib in Patients with Previously Treated BRCA-Mutated Pancreas Ductal Adenocarcinoma☆January 2018
  • Phase II Trial of Veliparib in Patients with Previously Treated BRCA-Mutated Pancreas Ductal Adenocarcinoma☆January 2018

Press Mentions

  • The National Cancer Institute Selects UChicago Medicine as a Lead Site for Clinical Trials
    The National Cancer Institute Selects UChicago Medicine as a Lead Site for Clinical TrialsJune 10th, 2026
  • ASCO’s Updated Mesothelioma Guidelines: What Oncologists Should Know
    ASCO’s Updated Mesothelioma Guidelines: What Oncologists Should KnowApril 22nd, 2025
  • Top Mesothelioma Cancer Center in Chicago Adding New Facility
    Top Mesothelioma Cancer Center in Chicago Adding New FacilityMarch 22nd, 2022

Grant Support

  • UG1 - NCTN (Network Lead)UNIVERSITY OF CHICAGO2019–2032
  • NCI National Clinical Trials Network Lead Academic Participating SiteNIH2014–2019
  • PI3K as a Therapeutic Target in Malignant Pleural MesotheliomaDepartment of Defense2012–2014
  • Cancer And Leukemia Group BNational Cancer Institute2009–2012
  • Novel Targeted Therapy In Pancreatic CancerNational Cancer Institute2009–2010

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Hedy Kindler, Dr. Hedy Kindler, MD, Dr. H Kindler, Dr. Hedy L Kindler